2024-07-17933.73 MB56页25
2024-07-17853.82 MB65页25
2024-07-171312.94 MB25页25
2024-07-171951.61 MB28页25
2024-07-1758221 KB18页25
2024-07-171328.26 MB32页25
2024-07-171461.72 MB25页25
2024-07-17123957.27 KB66页25
2024-07-171411.57 MB49页25
2024-07-1718328.77 MB10页25
2024-07-1713513.16 MB62页25
2024-07-198011.87 MB165页25
2024-07-21108915.58 KB17页25
2024-07-211612.58 MB21页25
2024-07-21165982.7 KB15页25
2024-07-222246.25 MB90页25
2024-07-2220716.05 MB126页25
2024-07-171831.39 MB31页24
“中国新靶点”数据分析赋能未满足临床需求药物研发王中健博士享融智云CEOhttps://www.pharnexcloud.com/目录CONTENTS01新药研发现状及热门靶点概述02深入挖掘“中国新靶点”03各适应症“中国新靶点”分析04总结https://www.pharnexcloud.com/全球新药数量分阶段统计124,521国内首家研发企业43,909国外首家研发企业80,61215,5905,0224,9266,1163,0271,413774787药物发现12,5634,1521,6155,329334临床前4604723,609II期临床1,281... 2024-07-172058.18 MB31页24
2024-07-171668.45 MB30页24